France's health advisory body recommends giving AstraZeneca's COVID-19 vaccine only to people under 65
The French guidance differs from that given by the European Medicines Agency, which authorized AstraZeneca's vaccine for use in all adults throughout the European Union
Paris: France's top health advisory body is recommending that the AstraZeneca coronavirus vaccine only be used on people under 65, citing lack of sufficient data about its effectiveness in older people.
The decision could shake up the French vaccination strategy, because the country has prioritised nursing home residents and people over 75. France had counted on the AstraZeneca vaccine for a large part of its upcoming inoculations, until the company announced delays affecting countries around Europe and the world.
The French guidance differs from that given by the European Medicines Agency, which authorized AstraZeneca's vaccine for use in all adults throughout the European Union on Friday, amid criticism the bloc is not moving fast enough to vaccinate its population.
Health authorities in Germany and other countries have raised concerns that the Anglo-Swedish company didn't test the vaccine in enough older people to prove it works for them, and indicated they would not recommend it for people over 65.
Just 94 out of 2,196 articles studied, contained content related to Africa and the articles relevant to Africa, just 210 out of 619 listed authors who were African.
The French Rugby Federation said the unnamed player tested positive following another round of tests late Wednesday, prompting their medical committee to suspend training.
Companies traditionally pour huge amounts of money and research into drugs and vaccines, for the right to profit from them.